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Fibroblast growth factor (Fgf) signaling plays important roles in brain development. Fgf3 and Fgf8 are crucial for the formation of the
forebrain and hindbrain. Fgf8 is also required for the midbrain to form. Here, we identified zebrafish Fgf19 and examined its roles in brain
development by knocking down Fgf19 function. We found that Fgf19 expressed in the forebrain, midbrain and hindbrain was involved in cell
proliferation and cell survival during embryonic brain development. Fgf19 was also essential for development of the ventral telencephalon and
diencephalon. Regional specification is linked to cell type specification. Fgf19 was also essential for the specification of g-aminobutyric acid
(GABA)ergic interneurons and oligodendrocytes generated in the ventral telencephalon and diencephalon. The cross talk between Fgf and Hh
signaling is critical for brain development. In the forebrain, Fgf19 expression was down-regulated on inhibition of Hh but not of Fgf3/Fgf8, and
overexpression of Fgf19 rescued partially the phenotype on inhibition of Hh. The present findings indicate that Fgf19 signaling is crucial for
forebrain development by interacting with Hh and provide new insights into the roles of Fgf signaling in brain development.
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During early embryonic brain development in vertebrates,
the neural plate is regionalized along the anteroposterior axis
and is subdivided into the forebrain, midbrain, hindbrain and
spinal cord. Subsequently, the forebrain becomes regionally
subdivided into the telencephalon and diencephalon. The
telencephalon comprises the rostrally positioned subpallial
(ventral) telencephalon and the more caudally located pallial
(dorsal) telencephalon, while the diencephalon contains the
hypothalamus, the ventral thalamus, the dorsal thalamus and
the pretectum (Wilson and Houart, 2004). In each region,
various cells with appropriate identities are generated in
appropriate numbers at precise positions and the neural
circuitry is formed. Intercellular signaling is crucial for the
control of cell fate specification and cell proliferation in the
developing brain. In the telencephalon, the dorsal region
coordinates growth and patterning via the production of two0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.09.042
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E-mail address: itohnobu@pharm.kyoto-u.ac.jp (N. Itoh).distinct classes of signal, the Tgfh family and Wnt family
(Wilson and Rubenstein, 2000). On the other hand, Hedgehog
(Hh) signaling is critical for the specification of ventral neurons
in the forebrain, and the proliferation of neural precursors in the
diencephalon and anterior midbrain (Chiang et al., 1996;
Briscoe et al., 2001; Varga et al., 2001). Fibroblast growth
factor (Fgf) signaling is also implicated in the regulation of cell
proliferation and differentiation in various regions during brain
development (Vasiliauskas and Stern, 2001; Wilson and
Houart, 2004).
Fgfs make up a large family comprising 22 members in
mammals (Itoh and Ornitz, 2004). Among them, Fgf8 is
required for normal development of the telencephalon,
midbrain and cerebellum. Mutant mice carrying an Fgf8
hypomorphic allele have telencephalic, midbrain and cerebellar
defects (Meyers et al., 1998; Garel et al., 2003). Zebrafish Fgf8
mutants also show alterations in the telencephalic gene
expression and fail to maintain the midbrain-hindbrain bound-
ary (MHB) gene expression (Reifers et al., 1998; Shanmuga-
lingam et al., 2000). Fgf3 is also expressed in the forebrain and
hindbrain (Mahmood et al., 1995; Walshe et al., 2002; Walshe
and Mason, 2003), and its ectopic expression affects the88 (2005) 259 – 275
www.e
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the forebrain (Koshida et al., 2002). The knockdown of both
Fgf3 and Fgf8 functions indicated that Fgf3 and Fgf8 possess
a unique and combinatorial function in the regional patterning
of the forebrain and hindbrain (Shinya et al., 2001; Walshe et
al., 2002; Maves et al., 2002; Walshe and Mason, 2003).
Mouse Fgf15 identified as a downstream target of the
chimeric homeodomain oncoprotein E2A-Pbx1 is expressed
early in the developing neural epithelium (McWhirter et al.,
1997; Zakin et al., 2000). At later stages, Fgf15 is expressed in
specific groups of neural cells (McWhirter et al., 1997; Gimeno
et al., 2003). Fgf15 expression at the early stage is regulated by
the expression of Otx2, a transcription factor that is crucial for
the regionalization and development of the anterior neural plate
and cephalic region of the vertebrate embryo (Zakin et al.,
2000). Human FGF19 is the human ortholog of mouse Fgf15
because both the human FGF19 and mouse Fgf15 genes are
closely linked to the human and mouse FGF3 and FGF4 genes
on orthologous regions of human chromosome 11q13 and
mouse chromosome 7F, respectively (Itoh and Ornitz, 2004).
Human FGF19 is also expressed preferentially in fetal brain
(Nishimura et al., 1999). Chick Fgf19 expressed in mesoderm
underlying the presumptive otic placode is involved in the otic
induction. Chick Fgf19 is also expressed in the embryonic
brain (Ladher et al., 2000). An analysis of Fgf15/ mice
indicated that Fgf15 is generally required for viability (Wright
et al., 2004). Most Fgf15/ mice died after E12.5. Therefore,
the roles of Fgf15 in the developing brain remain to be
elucidated, although Fgf15 is expected to participate in brain
development.
In the present study, we have identified zebrafish Fgf19
and examined its expression pattern and roles during brain
development in zebrafish. Our results have demonstrated that
Fgf19 is critical for both cell proliferation and cell survival in
the forebrain, midbrain and cerebellum. Furthermore, we have
shown that Fgf19 is also critical for the development of the
ventral region of the telencephalon and diencephalon and is
implicated in the specification of g-aminobutyric acid
(GABA)ergic interneurons and oligodendrocytes in the
telencephalon and diencephalon. Fgf3 and Fgf8 are implicat-
ed in regional patterning of the forebrain, and Fgf8 regulates
its own transcription and the transcription of Fgf3 in the
forebrain (Shinya et al., 2001; Shanmugalingam et al., 2000;
Walshe and Mason, 2003). Furthermore, cross talk between
the Fgf and Hh signaling pathways has been reported
(Brewster et al., 2000). However, it is not clear whether
these signaling pathways interact to specify cell fate and
promote cell proliferation in the brain. Thus, we have also
examined the cross talk of Fgf19 with Hh, Fgf3 and Fgf8 in
the brain.
Materials and methods
Fish maintenance
Zebrafish (Danio rerio) were maintained, referring to The Zebrafish Book
(Westerfield, 1995). Embryos were obtained by natural spawning and culturedat 28.5-C in Zebrafish Ringer’s solution. The developmental stages of the
embryos were determined by the hours post fertilization (hpf) and by
morphological features, as described by Kimmel et al. (1995).
Isolation and characterization of zebrafish Fgf19 cDNA
By BLAST (Basic Local Alignment Search Tool, http://www.ncbi.nlm.gov/
BLAST)-searching zebrafish genomic DNA sequences with the amino acid
sequence of human FGF19, zebrafish Fgf19 genomic DNAwas identified. The
full-length cDNA was isolated by PCR with zebrafish embryonic cDNA as a
template. The GenBank accession number for the Fgf19 cDNA is AB183515.
The positions of zebrafish Fgf19, Fgf3, Fgf4 and ccnd1 on chromosome
fragments were obtained from the Ensembl Zebrafish Genome Browser (http://
www.ensembl.org/Danio_rerio/). The map positions of human FGF19, FGF3,
FGF4 and CCND1 were obtained from LocusLink (http://www.ncbi.nlm.nih.
gov/genome/guide/).
Temporal expression profiles were determined by RT-PCR using the
following primers (5V primer/3V primer): Fgf19, CAAGACTGTCTTTAAT-
TACTGC/ACATCCACAAGAGATCAATACT (694 bp fragment) and ef1a,
ACCCTGGGAGTGAAACAGC/TTGCAGGCGATGTGAGCAG (689 bp
fragment).
Whole mount in situ hybridization
Digoxigenin-labeled RNA probes were synthesized by in vitro
transcription using T7 or SP6 RNA polymerase. A 0.7-kb Fgf19 probe
was synthesized using the full-length cDNA-containing plasmid. Other
probes used were zebrafish emx1 (Morita et al., 1995), tbr1 (Mione et
al., 2001), dlx2 (Akimenko et al., 1994), shh (Krauss et al., 1993),
pax6.1 (Krauss et al., 1991), isl1 (Inoue et al., 1994), otx2 (Mori et al.,
1994), mbx (Kawahara et al., 2002), eng2 (Ekker et al., 1992), Fgf8
(Reifers et al., 1998), Fgf3 (Phillips et al., 2001), her5 (Mu¨ller et al.,
1996), gad1, gad65 (Martin et al., 1998) and olig2 (Park et al., 2002).
Whole mount in situ hybridization was performed as previously described
(Koshida et al., 1998).
Morpholino and mRNA injection
Morpholino oligonucleotides (MOs) were synthesized by Gene-Tools, LLC
(Corvallis, OR). The sequences of MOs used are as follows: Fgf19 MO, 5V-
CAGTGACAAAGAGTAAGAGGAGCAT-3V; control Fgf19 MO, 5V-CAcTGt-
CAAAGAcTAAGAGcAGgAT-3V; Fgf3 MO, 5V-CATTGTGGCATGGCGG-
GATGTCGGC-3V; Fgf8 MO, 5V-GAGTCTCATGTTTATAGCCTCAGTA-3V;
and standard control MO, 5V-CCTCTTACCTCAGTTACAATTTATA-3V [Fgf3
and Fgf8 MOs have been used in previous studies; Maroon et al., 2002]. Small
letters in control Fgf19 MO indicate mismatched nucleotides in Fgf19 MO.
MOs were diluted in Danieau buffer (Nasevicius and Ekker, 2000). Fgf19 MO
and control Fgf19 MO were injected at 15 Ag/Al into four central blastomeres of
16-cell embryos. The injection of both Fgf3 MO and Fgf8 MO was performed
using a mixture of the two MOs. Fgf3 MO (10 Ag/Al) and Fgf8 MO (20 Ag/Al)
were injected at a volume of 0.15–0.25 nl into one- to two-cell embryos.
Standard control MO (15 Ag/Al) was injected at a volume of 0.5 nl into one- to
two-cell embryos.
For construction of Fgf19, the full-length Fgf19 cDNA was amplified by
PCR and inserted into the vector pCS2+ (Turner and Weintraub, 1994). Capped
Fgf19 mRNA was made by in vitro transcription using SP6 polymerase
(mMESSAGE mMACHINE; Ambion). The mRNA was diluted to 0.7 Ag/
Al with distilled water and was injected at a volume of 1.5 nl into four central
blastomeres of 16-cell embryos.
BrdU incorporation analysis
For 5-bromo-2V-deoxy-uridine (BrdU) uptake, about 1.5 nl of 10 mM
BrdU (Amersham Biosciences) was injected into the yolk of the embryos
at 13 hpf. Injected embryos were incubated in Zebrafish Ringer’s
solution for 3 h before being fixed. Immunochemical detection was
performed using a Cell Proliferation Kit (Amersham Biosciences) and
A. Miyake et al. / Developmental Biology 288 (2005) 259–275 261ABC staining kit (Vector Laboratory), as described previously (Shinya
et al., 2001). 3,3V-Diaminobenzidine tetrahydrochloride (DAB) was used
for visualization.
For cell counts, the stained embryos were embedded in Technovit 7100
(Heraeus Kulzer, Wehrheim) and cut into 4-Am serial sections. The sections
were counterstained with toluidine blue. Three sagittal sections at theFig. 1. Molecular analysis of zebrafish Fgf19. (A) The amino acid sequence of zeb
(mFgf15). The numbers refer to the amino acid positions of zebrafish Fgf19, human
sequences. Dashes indicate introduced gaps. (B) Phylogenetic tree comparing zebrafi
acid sequences. (C) Synthetic relationship between zebrafish chromosomal fragmen
FGF19 genes are closely linked to the zebrafish and human Fgf3, Fgf4 and ccnd1midline of the anterior brain from each treated embryo were selected, and
the total number of positive and negative cells within an area encompass-
ing the forebrain or the midbrain and cerebellum in each section was
counted. The boundary between the forebrain and midbrain was determined
using morphological criteria. Three control Fgf19 MO-injected and three
Fgf19 MO-injected embryos were examined. Data are expressed as therafish Fgf19 (zFgf19) aligned with human FGF19 (hFGF19) and mouse Fgf15
FGF19 and mouse Fgf15. Asterisks indicate identical amino acid residues in the
sh Fgf19 with human FGFs. The tree is based on a ClustalWalignment of amino
t ctg 11704 and human chromosome 11q13. Both zebrafish Fgf19 and human
genes. Mb, megabase.
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assessed with the Student’s t test.
H3P antibody staining and TUNEL assay
Dividing cells were detected using a rabbit polyclonal anti-phospho-
rylated histone H3 (H3P; Upstate Biotechnology) antibody, and apoptotic
cells were detected using the DeadEndi colorimetric detection kit
(Promega), as described previously (Maroon et al., 2002). The total
number of dividing cells within an area encompassing the forebrain,
midbrain and cerebellum was counted. Four wild-type and four Fgf19
mRNA-injected embryos at 16 hpf were examined. Data are expressed as
the mean T SD. The statistical significance of differences in mean values
was assessed with the Student’s t test.
Cyclopamine treatments
Cyclopamine (Toronto Chemical) (Incardona et al., 1998) was dissolved
at 10 mM in 95% ethanol. Embryos, in their chorions, were incubated in
cyclopamine diluted to 50 or 100 AM in Zebrafish Ringer’s solution starting
at the time points indicated. Control embryos were treated simultaneously
with an equal volume of 0.475% or 0.95% ethanol (cyclopamine carrier) in
Zebrafish Ringer’s solution. They were fixed at 15, 25 or 28 h with 4%
paraformaldehyde.
Results
Identification and characterization of zebrafish Fgf19
Among vertebrates, amino acid sequences of most
orthologous Fgfs are highly conserved (Itoh and Ornitz,
2004). By BLAST-searching the zebrafish genomic DNA
sequences with the amino acid sequence of human FGF19,
we identified a zebrafish amino acid sequence closely related
to human FGF19. We isolated the full-length cDNA
encoding the amino acid sequence from 24 hpf zebrafish
embryo cDNA. The cDNA encodes a protein of 209 amino
acids (Fig. 1A). Sequence comparison of this protein with
members of the human FGF family by phylogenetic analysis
indicates that the protein is most closely related to human
FGF19 (Fig. 1B). Human FGF19 is the human ortholog of
mouse Fgf15, although human FGF19 is not highly similar
(¨50% amino acid identity) to mouse Fgf15 (Itoh and
Ornitz, 2004). This protein is not highly similar to human
FGF19 (42% amino acid identity) or mouse Fgf15 (32%)
either (Fig. 1A). Human FGF19 and mouse Fgf15 are
closely linked to the FGF3, FGF4 and Cyclin D1 (CCND1)
genes in their orthologous chromosomal regions (Fig. 1C)
(Itoh and Ornitz, 2004). Therefore, we have examined this
gene’s location in the zebrafish genome. The gene is also
closely linked to the zebrafish Fgf3, Fgf4 and ccnd1 genesFig. 2. Expression pattern ofFgf19 during zebrafish embryonic development. (A) Am
shows results for zebrafish elongation factor 1-alpha (ef1a) as a control. (B–M) Ex
expressed throughout the embryo at 14 hpf. (C–F) 20 hpf. (C) Fgf19 was expressed in
Dorsal viewwith anterior to the top.Fgf19 was expressed in the retina adjacent to the l
tail bud mesenchyme (arrow). (F) Dorsal view of whole embryos, with anterior to the
expressed in the ventral thalamus, the ventral part of the telencephalon and the tectum a
vesicles. (I) Dorsal view with anterior to the top. Fgf19 expression was still promi
(arrowhead). (J) Fgf19 expression in the somites (arrow). (K–M) 36 hpf. (K) Fgf19 w
part of the telencephalon. (L)Fgf19 expression persisted in the lens but was no longer d
views with anterior to the left and dorsal to the top, except when indicated. di, diencon the chromosome (Fig. 1C). Thus, this gene was identified
as zebrafish Fgf19.Expression pattern of Fgf19
The temporal expression of Fgf19 during embryonic
development was first examined by RT-PCR. As shown in
Fig. 2A, Fgf19 expression was first detected at low levels at 11
hpf. Subsequently, the expression increased and was detected at
least until 48 hpf.
We then investigated the spatiotemporal expression pattern
of Fgf19 by whole mount in situ hybridization. At 14 hpf,
Fgf19 expression was widespread throughout the embryo (Fig.
2B). By 20 hpf, the expression was predominantly detected in
the ventral telencephalon, the anterior ventral thalamus, the
midbrain, the hindbrain, the retina adjacent to the lens and the
nasal part of the lens (Figs. 2C and D). In addition, a transient
expression of Fgf19 was detected in the tail bud mesenchyme
and in the otic placode at 20 hpf (Figs. 2E and F). At 24 hpf,
Fgf19 expression was detected in the ventral thalamus, the
ventral part of the telencephalon and tectum and the dorsal part
of the tegmentum in the brain (Fig. 2G). Fgf19 was also
expressed in the ventral domain of the otic vesicles at 24 hpf
(Fig. 2H). Furthermore, continuous expression was detected in
the lens and retina at 24 hpf (Fig. 2I). In addition, the
expression was transiently detected in the somites at 24 hpf
(Fig. 2J). At 36 hpf, Fgf19 was still expressed in the brain.
Notably, strong expression was observed in the cerebellum
(Fig. 2K). The expression was also detected in the lens at least
until 36 hpf but not in the retina (Fig. 2L). Besides the brain,
the expression was detected in the inner ear and intermediate
cell mass (ICM) (Fig. 2M and data not shown).
Inhibition of Fgf19 functions results in defects in formation of
the brain
Its expression in zebrafish embryonic brain suggests that
Fgf19 might contribute to the brain’s formation. We examined
the roles of Fgf19 in the brain’s formation. Injections of
antisense morpholino oligonucleotides (MOs) have recently
been demonstrated to effectively and specifically block the
corresponding gene functions in Xenopus and zebrafish
embryos (Heasman et al., 2000; Nasevicius and Ekker, 2000;
Maroon et al., 2002). As neuroectodermal derivatives mostly
result from four central blastomeres at the 16-cell stage (Helde
et al., 1994; Wilson et al., 1995), a MO encompassing the
initiation site of the Fgf19-coding sequence (Fgf19 MO) or aplification of zebrafishFgf19 by RT-PCR at the indicated stages. The lower pane
pression pattern detected by whole mount in situ hybridization. (B) Fgf19 wa
the ventral telencephalon, anterior ventral thalamus, midbrain and hindbrain. (D
ens (arrow) and the nasal part of the lens (arrowhead). (E) Fgf19 expression in the
top. Fgf19 expression in the otic placode (arrow). (G–J) 24 hpf. (G) Fgf19 wa
nd the dorsal part of the tegmentum in the brain. (H) Fgf19 expression in the otic
nent in the retina adjacent to the lens (arrow) and expanded to the entire len
as expressed in the thalamus, pretectum, midbrain, hindbrain and most posterio
etected in the retina. (M)Fgf19 was expressed in the ICM.All panels show latera
ephalon; hb, hindbrain; mb, midbrain; te, telencephalon.l
s
)
s
s
r
l
Fig. 3. Morphology of the Fgf19 MO-injected embryos. Embryos were injected
with control Fgf19 MO (A and C) and Fgf19 MO (B and D). (A and B) 60 hpf.
The Fgf19 MO-injected embryos had defects in the brain and eye. (C and D) 24
hpf. In the Fgf19 MO-injected embryos, the forebrain, midbrain and cerebellum
were reduced in size. Lateral views with anterior to the left and dorsal to the
top. di, diencephalon; hb, hindbrain; mb, midbrain; te, telencephalon. Scale
bars, 30 Am.
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Fgf19 MO) was injected into four central blastomeres of
zebrafish 16-cell embryos. The control Fgf19 MO-injected
embryos developed normally during embryogenesis (Figs. 3A
and C and data not shown). In contrast, the Fgf19 MO-injected
embryos showed abnormalities in brain and eye structures at
the 60-hpf stage (Figs. 3A and B). The Fgf19 MO-injected
embryos were morphologically distinguishable from the wild
type at 16 hpf. At 24 hpf, the embryos exhibited a significant
reduction in the size of the forebrain, the midbrain, the
hindbrain and the eyes (Figs. 3C and D; Table 1). These
results suggest that Fgf19 is required for normal growth of the
forebrain, midbrain and cerebellum during neurogenesis.
Fgf19 is required for cell proliferation and cell survival in the
forebrain, midbrain and hindbrain
The reduction in the size of the forebrain, midbrain and
cerebellum in the Fgf19 MO-injected embryos at 24 hpf
might be due to decreased cell proliferation in these
primordia. To examine this, we examined cell proliferation
by conducting an analysis of BrdU incorporation. In the wild-
type and control embryos, proliferating cells were mostly
detected in the dorsal region of the brain during mid-
segmentation stages (13¨16 hpf) (Fig. 4A). In contrast,
BrdU-positive cell numbers in the dorsal region of the
forebrain and the midbrain and cerebellum were significantlyTable 1
Phenotypes resulting from injection of Fgf19 MO in the zebrafish embryos
Normal Head d
Fgf19 MO (1.5 ng) 23% 60%
Control Fgf19 MO (1.5 ng) 97% 0%decreased (¨40% and ¨35% of control levels, respectively)
in the Fgf19 MO-injected embryos (Figs. 4A–D). To
determine whether Fgf19 promoted cell proliferation, we
compared the number of mitotic cells in the wild-type and
Fgf19 mRNA-injected embryos. We detected mitotic cells in
M-phase using an antibody directed against phosphorylated
histone H3, which specifically detected cells in M-phase
(H3P; Hendzel et al., 1997). Injection of Fgf19 mRNA
increased the number of mitotic cells compared with the wild-
type embryos at 16 hpf (Figs. 4E–G). Next, we examined
whether the inhibition of Fgf19 functions affected apoptosis.
The wild-type and Fgf19 MO-injected embryos were assayed
for apoptotic cells via TUNEL labeling. At 16 hpf, few
apoptotic cells were detected in the entire brain of wild-type
embryos (Fig. 4H). The number of apoptotic cells in the brain
of Fgf19 MO-injected embryos was increased compared with
that in the wild type in all embryos examined (n = 24) (Fig.
4I). These results indicate that Fgf19 appears to be required
for cell proliferation and cell survival in the forebrain,
midbrain and cerebellum at mid-somitogenesis.
Fgf19 is required for the development of subpallial
telencephalon and anterior ventral thalamus
Fgf3 and Fgf8 are implicated in patterning events in the
forebrain and hindbrain (Shinya et al., 2001; Walshe et al.,
2002; Maves et al., 2002; Walshe and Mason, 2003).
Therefore, we investigated whether Fgf19 was also involved
in the regionalization of the brain. First, the expression of
forebrain marker genes was analyzed in the Fgf19 MO-
injected embryos at 25 hpf. The expression of emx1, which is
normally detected in the pallial domain of the telencephalon,
was observed in the entire region of the telencephalon in the
Fgf19 MO-injected embryos (n = 22/22) (Figs. 5A and B).
Furthermore, the expression of tbr1, which normally occurs in
the pallial telencephalon, also was detected in the entire
telencephalon with the inhibition of Fgf19 signaling (n = 20/
20) (Figs. 5C and D). In contrast to emx1 and tbr1 expression,
the expression of pax6.1, which is normally detected in the
telencephalon, was reduced in the Fgf19 MO-injected
embryos (n = 14/18) (Figs. 5E and F). We also analyzed
the expression of dlx2 that is normally detected in the ventral
region of the telencephalon. In the Fgf19 MO-injected
embryos, dlx2 expression in the ventral telencephalon was
reduced (n = 24/26) (Figs. 5G and H). In the wild-type
embryos, dlx2 expression in the telencephalon was initially
detected at 16 hpf, while a loss of dlx2 expression in the
telencephalon was observed in the Fgf19 MO-injected
embryos at 16 hpf (n = 28/29) (Figs. 5I and J). In contrast,
all control embryos showed normal expression patterns ofefect General defects Total embryos (n)
17% 65
3% 54
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the loss of the subpallial telencephalon in the Fgf19 MO-
injected embryos.
We also examined whether inhibition of Fgf19 affected
diencephalic specification. In the diencephalon, dlx2 is
normally expressed in the ventral thalamus. The expression
of dlx2 in the anterior ventral thalamus was eliminated in the
Fgf19 MO-injected embryos (n = 26/26) (Figs. 5G and H).
However, the expression of dlx2 in the anterior ventral
thalamus was observed in the Fgf19 MO-injected embryos at
16 hpf (n = 29/29) (Figs. 5I and J). The zona limitans
intrathalamica (zli) is considered to be a prominent anteropos-
terior (AP) boundary in the forebrain separating the rostral
forebrain (the telencephalon, eyes, hypothalamus and ventral
thalamus) from the caudal diencephalon (the dorsal thalamusFig. 4. Comparison of cell proliferation and cell death patterns in control embryos a
with control Fgf19 MO (A) and Fgf19 MO (B) were labeled with BrdU and stained
the top. (A) BrdU-positive cells (light brown in A) were mostly detected in the dorsa
sections of the head region of stained embryos that show fewer labeled cells (light
BrdU-positive cells in the forebrain (C) and the midbrain and cerebellum (D) of the c
examined by counting BrdU-positive and -negative cells in the sections. Results are
indicate statistical significance compared with the control (*P < 0.005). The forebrai
the sections, are separated by black lines. (E and F) Wild-type embryos (E) and emb
Lateral views with anterior to the left and dorsal to the top. Increased numbers of H3
Fgf19 mRNA-injected embryos compared with the wild-type embryos at 16 hpf. (G)
wild-type and Fgf19 mRNA-injected embryos were counted. Results are the means
the wild type (*P < 0.05). (H and I) Apoptotic cells in the wild-type embryos (H) and
views with anterior to the left. Substantially, increased numbers of apoptotic cells
embryos at 16 hpf.and pretectum). The zli is likely to locally regulate the
development of the ventral and dorsal thalamus through Hh
signaling (Ishibashi and McMahon, 2002; Hashimoto-Torii et
al., 2003). Therefore, we examined the effects of Fgf19
inhibition on the formation of the zli. shh is normally expressed
in the zli. The expression of shh in the zli was unaffected in the
Fgf19 MO-injected embryos (n = 21/21) (Figs. 5K and L). This
suggested that the zli is formed normally in the Fgf19 MO-
injected embryos. In the diencephalon, pax6.1 and otx2 are
normally expressed in the dorsal thalamus, posterior ventral
thalamus and pretectum and the dorsal thalamus, respectively.
The expression of pax6.1 and otx2 was detected in the
diencephalon of the Fgf19 MO-injected embryos (n = 18/18
and n = 16/16), respectively (Figs. 5E, F and 6A, B). Thus,
Fgf19 was required for the development of the anterior part ofnd Fgf19 MO- or Fgf19 mRNA-injected embryos. (A and B) Embryos injected
using an anti-BrdU antibody. Lateral views with anterior to the left and dorsal to
l region of the brain in the control embryos at 16 hpf. (B) Representative sagittal
brown in B) in the Fgf19 MO-injected embryos. (C and D) The proportions of
ontrol Fgf19 MO-injected and Fgf19 MO-injected embryos were quantitatively
the means T SD for three independent sections from three embryos. Asterisks
n (fb), and the midbrain and cerebellum (mb + cb) regions, which we defined in
ryos injected with Fgf19 mRNA (F) were stained using an anti-H3P antibody.
P-positive cells (dark brown in panel F) were detected in the head region of the
Numbers of H3P-positive cells in the forebrain, midbrain and cerebellum of the
T SD for four embryos. Asterisks indicate statistical significance compared with
embryos injected with Fgf19 MO (I) were marked by TUNEL staining. Dorsal
(light brown in I) were detected in the head region of the Fgf19 MO-injected
Fig. 5. Telencephalic and diencephalic gene expression in the Fgf19 MO-injected embryos. Embryos were injected with control Fgf19 MO (A, C, E, G, I, K and M)
and Fgf19 MO (B, D, F, H, J, L and N). (A–D) The pallial telencephalic markers, emx1 (A and B) and tbr1 (C and D) were expressed in both the pallial and
subpallial telencephalon in the Fgf19 MO-injected embryos at 25 hpf. Arrows in panels A and C indicate the subpallial telencephalon that is negative for emx1 or
tbr1. (E and F) In the Fgf19 MO-injected embryos, pax6.1 expression in the posterior ventral thalamus (arrow) and dorsal thalamus was unaltered, while the
expression in the telencephalon (arrowhead) was reduced at 25 hpf. (G and H) In the Fgf19 MO-injected embryos, dlx2 expression was completely lost in both the
posterior ventral telencephalon (arrowhead) and anterior ventral thalamus (arrow) at 25 hpf. (I and J) In the Fgf19 MO-injected embryos, dlx2 expression in the
ventral thalamus was unaltered, while the expression in the telencephalon was lost at 16 hpf. (K and L) shh was expressed in similar domains in the control Fgf19
MO-injected and Fgf19 MO-injected embryos at 25 hpf. Arrowheads indicate the zli. (M and N) In the Fgf19 MO-injected embryos, isl1 expression is virtually
undetectable in the subpallial telencephalon and reduced in the ventral thalamus and epiphysis at 25 hpf. Lateral views with anterior to the left and dorsal to the top.
Dots indicate the boundary between the telencephalon and ventral diencephalon.
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thalamus and formation of the zli.
Furthermore, we examined whether the injection of Fgf19
MO affected neuronal differentiation in the forebrain at 25 hpf.
In the forebrain, isl1, a neuronal marker gene, is expressed by
ventral neurons in the telencephalon and diencephalon, and by
neurons in the epiphysis. In the Fgf19 MO-injected embryos,
isl1 expression was virtually absent in the ventral telenceph-
alon and reduced in the ventral diencephalon and the epiphysis
(n = 23/23) (Figs. 5M and N). This result indicates thatneuronal differentiation in the ventral region in both the
telencephalon and the diencephalon is suppressed in the
Fgf19 MO-injected embryos.
Fgf19 is not required for patterning of the midbrain and
cerebellum
To investigate the involvement of Fgf19 in the development
of the midbrain and cerebellum, we examined the expression of
otx2, mbx and eng2, midbrain and cerebellum marker genes, in
Fig. 7. Interactions between Fgf19, Fgf3 and Fgf8 in the forebrain and
midbrain. (A–D) Embryos were injected with control Fgf19 MO (A and C),
Fgf19 MO (B and D) at 25 hpf. In the Fgf19 MO-injected embryos, Fgf3 (A
and B) and Fgf8 (C and D) were expressed normally in the MHB (arrows) but
the expression of Fgf3 and Fgf8 was up-regulated in the forebrain (arrow-
heads). (E and F) Fgf19 expression in embryos injected with standard control
MO (E), and Fgf3 MO and Fgf8 MO (F) at 25 hpf. (E) In the embryos injected
with standard control MO, Fgf19 was normally expressed. (F) In the embryos
injected with both Fgf3 MO and Fgf8 MO, Fgf19 expression in the forebrain
was unaffected, while that in the midbrain (arrow) decreased. Lateral views
with anterior to the left and dorsal to the top.
Fig. 6. Expression of region-specific markers in the midbrain and cerebellum in
the Fgf19 MO-injected embryos at 25 hpf. Embryos were injected with control
Fgf19 MO (A, C, E and G) and Fgf19 MO (B, D, F and H). (A and B) In the
Fgf19 MO-injected embryos, otx2 expression was detected in the dorsal
thalamus and midbrain, while the expression domains were smaller in the
Fgf19 MO-injected embryos than in the control Fgf19 MO-injected embryos.
Furthermore, otx2 expression in the olfactory epithelium was lost. (C–F) mbx
(C and D) and eng2 (E and F) were expressed in similar regions in the control
Fgf19 MO-injected and Fgf19 MO-injected embryos, while the expression
domains were smaller in the Fgf19 MO-injected embryos than in the control
Fgf19 MO-injected embryos. (G and H) Expression of her5 in the MHB was
normal in the Fgf19 MO-injected embryos. Lateral views with anterior to the
left and dorsal to the top. Arrows in panels G and H indicate the MHB.
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are normally expressed in the dorsal thalamus and midbrain,
the pretectum and midbrain and the posterior midbrain and
cerebellum, respectively. In the Fgf19 MO-injected embryos,
the expression of otx2, mbx and eng2 was detected in the
dorsal thalamus and midbrain, the pretectum and midbrain and
the posterior midbrain and cerebellum (n = 16/16, n = 16/16
and n = 22/22), respectively (Figs. 6A–F). However, the
injection of Fgf19 MO led to a marked decrease in the size of
the otx2, mbx and eng2 expression domains because the size of
the midbrain and cerebellum was decreased (Figs. 6A–F).
These results indicate that the midbrain- and cerebellum-
specific characteristics are not affected by Fgf19 MO.
The MHB, the local organizing center, is crucial for the
induction and patterning of the midbrain and cerebellum
(Martinez, 2001; Rhinn and Brand, 2001; Wurst and Bally-
Cuif, 2001). Therefore, to examine whether a reduction of the
midbrain and cerebellum territory is not due to a defect in theMHB, we examined the expression of her5, Fgf8 and Fgf3,
MHB marker genes, in the Fgf19 MO-injected embryos at 25
hpf. Fgf19 MO did not affect the expression pattern of her5,
Fgf8 and Fgf3 in the MHB (n = 21/21, n = 20/20 and n = 16/
16, respectively) (Figs. 6G, H and 7A–D). Thus, the MHB was
formed normally in the Fgf19 MO-injected embryos. These
results indicate that Fgf19 expressed in the midbrain and
cerebellum regulates the growth of the midbrain and cerebel-
lum directly and not via the MHB.
Fgf3 and Fgf8 expression in the telencephalon is up-regulated
by inhibition of Fgf19 functions
In the forebrain, the expression of Fgf19 was detected later
than that of Fgf3 or Fgf8. Fgf3 and Fgf8 are first expressed in
the anterior neuroectoderm at 8 hpf and anterior neural boundary
(ANB) at the tail bud stage (10 hpf), respectively. By 12 hpf,
both genes are expressed within the dorsal telencephalon
(Walshe and Mason, 2003). Recent studies also show the
involvement of Fgf3 and Fgf8 in the regional patterning of the
telencephalon and diencephalon. Inhibition of Fgf3 and Fgf8
results in defects in expression of genes associated with early
patterning functions in the forebrain (Shinya et al., 2001;Walshe
and Mason, 2003). Furthermore, Fgf8 regulates its own
expression and Fgf3 expression in the forebrain (Shanmuga-
lingam et al., 2000; Walshe and Mason, 2003). Therefore, to
examine whether Fgf19 expression was affected by inhibition
of both Fgf3 and Fgf8 during forebrain development, we
examined Fgf19 expression in Fgf3 MO- and Fgf8 MO-
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results in an expansion of the expression of the pallial
telencephalic marker genes and reduction of the expression of
the subpallial telencephalic marker genes (Shinya et al., 2001;
Walshe and Mason, 2003). We also observed an expansion of
emx1 expression and reduction of dlx2 expression in the
embryos injected with both Fgf3 MO and Fgf8 MO at 25 hpf
(data not shown). In such embryos, Fgf19 expression in the
forebrainwas unaffected at both 15 and 25 hpf (n = 17/19 and n =
34/36, respectively) (Figs. 7E, F and 9E, G). In addition to
patterning defects in the forebrain, the embryos injected with
both Fgf3 MO and Fgf8 MO lack a cerebellum and do not
express midbrain marker genes because Fgf8 is involved in the
development of the midbrain and cerebellum (Reifers et al.,
1998). Therefore, we examined whether Fgf19 expression was
affected in the midbrain by inhibition of both Fgf3 and Fgf8. In
contrast to the forebrain, injection of both Fgf3 MO and Fgf8
MO led to a reduction of Fgf19 expression in the midbrain at
both 15 and 25 hpf (n = 19/19 and n = 36/36, respectively) (Figs.
7E, F and 9E, G). These results indicate that a combinatorial
function of Fgf3 and Fgf8 is involved in the regulation of Fgf19
expression in the midbrain but not in the forebrain. Furthermore,
we examined whether Fgf3 and Fgf8 expression in the forebrain
was affected by inhibition of Fgf19. In the forebrain, Fgf3 and
Fgf8 are normally expressed in the hypothalamus and in the
anterior telencephalon and optic stalks, respectively. Fgf19 MO
caused a strong expansion of Fgf8 expression in the telenceph-
alon at 25 hpf (n = 19/20) (Figs. 7C and D). In the Fgf19 MO-
injected embryos, Fgf3 expression was also up-regulated in the
telencephalon and in the hypothalamus (n = 13/16) (Figs. 7A
and B). These results indicate that the ectopic expression of Fgf3
and Fgf8 is induced in the telencephalon of the Fgf19 MO-
injected embryos.
Fgf19 is required for GABAergic interneuron and
oligodendrocyte development
Cell type specification is linked to regional specification
within the forebrain. In the telencephalon, significant numbers
of inhibitory GABAergic interneurons and oligodendrocytes
arise from the subpallium, and migrate tangentially to the
pallium (Corbin et al., 2001; Marin and Rubenstein, 2001). In
the diencephalon, GABAergic interneurons and oligodendro-
cytes are generated in the ventral thalamus and the ventral
thalamus and dorsal thalamus, respectively (Jones, 2001;
Hayes et al., 2003). Dlx2 is involved in the specification of
both cell types (Bertrand et al., 2002). The reduction in the
expression of dlx2 in embryos injected with either Fgf19 MO
or Fgf3 MO and Fgf8 MO indicates that specification of
GABAergic interneurons and oligodendrocytes in ventral
regions of the forebrain may also be affected.
gad1 is a gene that encodes glutamic acid decarboxylase,
which controls the rate-limiting step in GABA synthesis, and
expressed specifically in GABAergic interneurons (Martin et
al., 1998). Therefore, we examined gad1 expression in the
forebrain. In the forebrain, gad1 is expressed in the ventral
telencephalon and the nucleus of the tract of the postopticcommissure (nTPOC) (Martin et al., 1998). In the Fgf19 MO-
injected embryos, gad1 expression was severely reduced in
both the ventral telencephalon and the nTPOC (n = 25/25)
(Figs. 8A and B). On the other hand, the co-injection of Fgf3
MO and Fgf8 MO resulted in a slight reduction of gad1
expression in the ventral telencephalon, whereas a severe
reduction of gad1 expression was observed in the nTPOC (n =
23/23) (Fig. 8C). In the forebrain, gad65, which encodes an
isoform of glutamic acid decarboxylase, is also expressed in the
ventral telencephalon and the nTPOC (Martin et al., 1998). In
the Fgf19 MO-injected embryos, gad65 expression was also
reduced severely in both the ventral telencephalon and the
nTPOC (n = 15/15) (data not shown). These results demon-
strate that the specification of GABAergic interneurons in the
ventral diencephalon is suppressed in the embryos injected
with either Fgf19 MO, or Fgf3 MO and Fgf8 MO, while
specification of GABAergic interneurons in the ventral
telencephalon is suppressed in the embryos injected with
Fgf19 MO but not Fgf3 MO and Fgf8 MO.
To investigate the involvement of Fgf19, Fgf3 and Fgf8 in
oligodendrocyte specification, we examined olig2 expression
in embryos injected with Fgf19 MO, or Fgf3 MO and Fgf8
MO. olig2 is expressed in the oligodendrocyte precursors and
is necessary and sufficient for the generation of oligodendro-
cytes throughout the neuraxis (Marquardt and Pfaff, 2001;
Sauvageot and Stiles, 2002; Park et al., 2002). In the forebrain,
olig2 is expressed in the subpallial telencephalon, the ventral
thalamus and the dorsal thalamus (Park et al., 2002). The
injection of Fgf19 MO did not affect olig2 expression in the
dorsal thalamus, whereas olig2 expression in the subpallial
telencephalon and the ventral thalamus was significantly
reduced (n = 21/23) (Figs. 8E and F). In the Fgf3 MO- and
Fgf8 MO-injected embryos, olig2 expression was reduced in
the subpallial telencephalon, the anterior ventral thalamus and
the zli (n = 25/26) (Fig. 8G). These results indicate that
specification of oligodendrocytes in ventral regions in the
forebrain is suppressed in the embryos injected with either
Fgf19 MO, or Fgf3 MO and Fgf8 MO.
Because of decreased cell proliferation, increased apoptosis
and the loss of subpallial fate in the forebrain of the Fgf19 MO-
injected embryos, there is possibility that the loss of gad1 and
olig2 expression may be secondary effects due to earlier
failures in cell proliferation, cell death or proper patterning of
the forebrain. Therefore, to investigate whether the Fgf19 level
is sufficient to influence the fate of GABAergic interneurons
and oligodendrocytes, we examined dlx2, emx1, gad1 and
olig2 expression in embryos injected with Fgf19 mRNA. In the
Fgf19 mRNA-injected embryos, dlx2 expression was up-
regulated in the telencephalon and in the ventral thalamus at
26 hpf (n = 11/16) (Figs. 8I and J). On the other hand, emx1
expression in the telencephalon was down-regulated in the
Fgf19 mRNA-injected embryos at 26 hpf (n = 14/17) (Figs. 8K
and L). This indicates that overexpression of Fgf19 promotes
subpallial fate. Furthermore, in the Fgf19 mRNA-injected
embryos, gad1 and olig2 expression in the telencephalon
expanded slightly into the pallial domain, and gad1 and olig2
expression in the diencephalon was significantly up-regulated
Fig. 8. Specification of GABAergic interneurons and oligodendrocytes. (A–D) gad1 expression in wild-type embryos (A) and embryos injected with Fgf19 MO (B),
Fgf3 MO and Fgf8 MO (C) or Fgf19 mRNA (D) at 28 hpf. (B) The injection of Fgf19 MO resulted in a severe reduction of gad1 expression in both the ventral
telencephalon and nTPOC. (C) In the embryos injected with both Fgf3 MO and Fgf8 MO, gad1 expression in the nTPOC was severely reduced, while that in the
ventral telencephalon decreased slightly. (D) The injection of Fgf19 mRNA resulted in increased expression of gad1 in the forebrain. (E–H) olig2 expression in
wild-type embryos (E) and embryos injected with Fgf19 MO (F), Fgf3 MO and Fgf8 MO (G) or Fgf19 mRNA (H) at 28 hpf. (F) In the embryos injected with Fgf19
MO, olig2 expression in the dorsal thalamus was unaffected, while that in the subpallial telencephalon and ventral thalamus decreased significantly. (G) In the
embryos injected with both Fgf3 MO and Fgf8 MO, olig2 expression in the subpallial telencephalon, anterior ventral thalamus and zli (arrow) was reduced, while
that in the posterior ventral thalamus and dorsal thalamus was unaffected. (H) In the embryos injected with Fgf19 mRNA, olig2 expression in the forebrain increased
significantly. (I and J) dlx2 expression in wild-type embryos (I) and embryos injected with Fgf19 mRNA (J) at 26 hpf. (J) The injection of Fgf19 mRNA resulted in
increased expression of dlx2 in the telencephalon and diencephalon. (K and L) emx1 expression in wild-type embryos (K) and embryos injected with Fgf19 mRNA
(L) at 26 hpf. (L) The injection of Fgf19 mRNA resulted in decreased expression of emx1 in the telencephalon. Lateral views with anterior to the left and dorsal to
the top. Dots indicate the boundary between the telencephalon and ventral diencephalon.
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These findings demonstrate that overexpression of Fgf19
influences GABAergic neuronal and oligodendrocyte fate in
the ventral telencephalon and diencephalon.
Hh signaling is required for Fgf19, Fgf3 and Fgf8 expression
in the brain
The involvement of Fgf19 in the regionalization and the
generation of specific cell types such as GABAergic interneur-
ons and oligodendrocytes in the forebrain prompted us to
investigate the regulatory mechanisms of Fgf19 expression. Hh
molecules produced in the ventral forebrain also function in
dorsoventral (DV) forebrain patterning. The expression of
several forebrain marker genes is affected in slow muscle
omitted (smu) mutants, where the function of smoothened, that
transduced hedgehog signals, was lost (Varga et al., 2001). Inaddition, Hh signaling is required for Olig2 expression in
zebrafish and mouse (Alberta et al., 2001; Park et al., 2002) and
Shh promotes GABAergic neuronal/oligodendrocyte lineage
restriction of forebrain stem cells (Yung et al., 2002). Further-
more, the cross talk between Fgf and Hh signaling is critical for
brain development (Brewster et al., 2000). Therefore, we
examined whether the expression of Fgf19, Fgf3 and Fgf8
was responsive to Hh signaling. Because the alkaloid cyclopa-
mine completely blocked Hh signaling at the level of Smooth-
ened (Taipale et al., 2000), we examined the expression of
Fgf19, Fgf3 and Fgf8 in embryos treated with cyclopamine. The
embryos treated with cyclopamine from 5 hpf onwards showed
an expansion of emx1 expression in the telencephalon and
reduction of dlx2 expression in the ventral forebrain at 25 hpf
(n = 11/11 and n = 21/21, respectively) (Figs. 9H and I, and data
not shown). This phenotype was consistent with that of smu
mutants (Varga et al., 2001). In the embryos treated with
Fig. 9. Regulation of Fgf19, Fgf3 and Fgf8 by Hh signaling. (A–D) Expression of Fgf3 (A and B) and Fgf8 (C and D) in embryos treated with 0 AM (A and C) or
100 AM (B and D) cyclopamine at 15 hpf. The treatment of wild-type embryos with 100 AM cyclopamine did not affect Fgf3 and Fgf8 expression in the MHB, while
the expression of Fgf3 and Fgf8 in the telencephalon (arrows) was markedly reduced. (E–G) Fgf19 expression in wild-type embryos (E), embryos treated with 100
AM cyclopamine (F) and embryos injected with Fgf3 MO and Fgf8 MO (G) at 15 hpf. (F) Fgf19 expression in the cyclopamine-treated embryos was reduced in the
forebrain (arrowhead), midbrain (arrow) and cerebellum. (G) In the embryos injected with both Fgf3 MO and Fgf8 MO, Fgf19 expression in the forebrain was
unaffected, while that in the midbrain (arrow) decreased. (H–K) Expression of dlx2 (H and I) and Fgf19 (J and K) in embryos treated with 0 AM (H and J) or
100 AM (I and K) cyclopamine at 25 hpf. (H and I) The treatment of wild-type embryos with 100 AM cyclopamine strongly reduced dlx2 expression in the ventral
thalamus. (J and K) Fgf19 was normally expressed in the control embryos (J), while Fgf19 expression in the cyclopamine-treated embryos was extremely reduced in
the forebrain, midbrain and cerebellum (K). Lateral views with anterior to the left and dorsal to the top. (L and M) Expression of gad1 in embryos treated with 0 AM
(L) or 50 AM (M) cyclopamine. The treatment of wild-type embryos with 50 AM cyclopamine strongly reduced gad1 expression in the telencephalon and lost gad1
expression in the diencephalon at 28 hpf. (N) Expression of gad1 in embryos injected with Fgf19 mRNA and treated with 50 AM cyclopamine. The expression of
gad1 in the telencephalon and diencephalon was rescued by injection of Fgf19 mRNA at 28 hpf. (O and P) Expression of olig2 in embryos treated with 0 AM (O) or
50 AM (P) cyclopamine. The treatment of wild-type embryos with 50 AM cyclopamine strongly reduced olig2 expression in the forebrain at 28 hpf. (Q) Expression
of olig2 in embryos injected with Fgf19 mRNA and treated with 50 AM cyclopamine. The expression of olig2 in the forebrain was rescued by injection of Fgf19
mRNA at 28 hpf. Frontal views with dorsal to the top.
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reduced in the forebrain at 15 hpf, whereas the expression of
Fgf3 and Fgf8 in the MHB was not affected (n = 17/17 and n =
17/17, respectively) (Figs. 9A–D). On the other hand, Fgf19
expression was strongly reduced in the forebrain, midbrain and
cerebellum in embryos treated with cyclopamine at 15 and 25
hpf (n = 19/19 and n = 27/27, respectively) (Figs. 9E, F, J andK).
All control embryos showed normal expression patterns for
these genes (Figs. 9A, C, E, H and J). These findings indicate
that the expression of Fgf3 and Fgf8 in the forebrain and the
expression of Fgf19 in the forebrain, midbrain and cerebellum
are dependent on Hh signaling.
Next, to determinewhetherFgf19 regulates the differentiation
of GABAergic interneurons and oligodendrocytes as the down-
stream factor of theHh signaling cascade,we examinedgad1 and
olig2 expression in embryosboth injectedwithFgf19mRNAand
treatedwith cyclopamine.The embryos treatedwith cyclopamine
from9hpfonwards showedastrong reductionofgad1 expression
in the telencephalon and a loss of gad1 expression in the
diencephalon at 28 hpf (n = 30/30) (Figs. 9L and M). In the
embryos both injected with Fgf19 mRNA and treated with
cyclopamine, the expression of gad1 in the telencephalon and the
diencephalon was up-regulated compared with the embryos
treated with cyclopamine (n = 12/24) (Figs. 9M and N).
Furthermore, there was no olig2 detected in the telencephalon
and its expression in the diencephalon was strongly reduced in
embryos treatedwith cyclopamine at 28 hpf (n = 30/30), whereas
olig2 expression was significantly up-regulated in the dienceph-
alon of the embryos both injected with Fgf19 mRNA and treated
with cyclopamine (n = 14/24) (Figs. 8O–Q). These results
indicate that Fgf19 partially rescues the phenotype caused by
inhibition of Hh signaling in the specification of GABAergic
interneurons and oligodendrocytes in the forebrain.
Discussion
In the present study, we have identified the zebrafish Fgf19
gene. The zebrafish Fgf19 gene was located at the synthetic
locus of the human FGF19 gene as well as mouse Fgf15 gene.
No paralog of the Fgf19 gene has been found in the zebrafish
genome. Recently, another group reported the same result
(Katoh and Katoh, 2003). Fgf19 was first expressed widely in
the embryo at 14 hpf. Subsequently, the expression was
predominant in the ventral telencephalon, anterior ventral
thalamus, midbrain and anterior hindbrain by 20 hpf. This
suggests that Fgf19 may be involved in the brain’s formation. To
date, no zebrafish mutant has been mapped to the Fgf19 locus.
Therefore, in the present paper, we have focused on elucidating
the roles of Fgf19 in the development of the brain and inhibited
the function of Fgf19 in neuroectodermal derivatives by using
the knockdown-of- and gain-of-function approaches.
Roles of Fgf19 in cell proliferation and cell survival during
brain development
Inhibition of Fgf19 functions affected cell proliferation and
cell survival in the brain during mid-segmentation stages (13–16 hpf) and led to a reduction in the size of the forebrain,
midbrain and cerebellum at 24 hpf. The MHB is crucial for the
growth and patterning of the midbrain and cerebellum
(Martinez, 2001; Rhinn and Brand, 2001; Wurst and Bally-
Cuif, 2001). Fgf8 required for MHB development is also
involved in the proliferation of the midbrain (Sato et al., 2001).
However, the Fgf19 MO-injected embryos showed normal
expression patterns of MHB marker genes, her5, Fgf8 and
Fgf3, and had normal MHB-specific characteristics. This
indicates that the decreased cell proliferation and the increased
apoptosis in the midbrain and cerebellum of the Fgf19 MO-
injected embryos during mid-segmentation stages are not due
to a defect in the MHB. Furthermore, the increase in mitotic
cell numbers on overexpression of Fgf19 indicated that the
reduction in BrdU-positive cell numbers in the Fgf19 MO-
injected embryos was due to both decreased cell proliferation
and increased cell death. Thus, Fgf19 functions are required to
promote cell proliferation and enhance cell survival in the
forebrain, midbrain and cerebellum at mid-somitogenesis.
Roles of Fgf19 in regionalization during brain development
With the inhibition of Fgf19, the expression pattern of
emx1, tbr1, pax6.1 and dlx2, the genes associated with
forebrain patterning, was also changed in the telencephalon
and ventral thalamus. Fgf19 MO-injected embryos showed an
expanded expression of markers for the pallial telencephalon,
emx1 and tbr1 at 25 hpf. Furthermore, the expression of pax6.1
and dlx2 was decreased in the telencephalon by inhibition of
Fgf19 at 25 hpf. These results indicate the loss of subpallial
cells in the telencephalon. Induced cell death and reduced cell
proliferation in the telencephalon were observed in the Fgf19
MO-injected embryos. For the phenotype, there are at least two
possibilities. (1) Fgf19 regulates cell proliferation throughout
the brain at the early stage and is involved in patterning of the
ventral forebrain at the late stage, and the ventral telencephalon
develops into the pallium but not subpallium by inhibition of
Fgf19. (2) Subpallial cells are formed in smaller numbers due
to reduced cell proliferation caused by inhibition of Fgf19.
However, the following two observations suggest the first
possibility. First, dlx2 was not detected in the Fgf19 MO-
injected embryos at 16 hpf, suggesting that the subpallial fate
was not induced from the beginning. Second, overexpression
of Fgf19 resulted in increased cell proliferation in both the
pallial and subpallial telencephalon, whereas dlx2 expression
was up-regulated and emx1 expression was down-regulated in
the telencephalon by overexpression of Fgf19. Although Fgf19
was expressed throughout the entire telencephalon including
both the pallial and subpallial regions during mid-segmentation
stages, inhibition of Fgf19 affected the expansion of the pallial
region into the subpallial region. Fgf signaling is mediated by
Fgf receptors (Itoh and Ornitz, 2004). Human FGF19 binds to
human FGFR4 in vitro (Xie et al., 1999). Zebrafish Fgfr4 is
expressed in the ventral telencephalon at 24 hpf (Tonou-
Fujimori et al., 2002). Therefore, patterning of the ventral
forebrain by Fgf19 signaling may be mediated through Fgfr4.
Furthermore, the expression of Fgf19 in the telencephalon was
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of dlx2 was also decreased in the anterior ventral thalamus by
inhibition of Fgf19 at 25 hpf, whereas the expression of dlx2
was unaffected in the anterior ventral thalamus by inhibition of
Fgf19 at 16 hpf. This demonstrates that the anterior ventral
thalamus is initially induced. On the other hand, the expression
of otx2 and mbx was detected in the caudal diencephalon and
they were not expressed in the rostral forebrain of the Fgf19
MO-injected embryos. These results indicate that Fgf19 is also
necessary for maintenance of the characteristics of the anterior
ventral thalamus. In contrast, midbrain- and cerebellum-
specific characteristics were unaffected in the Fgf19 MO-
injected embryos. This result indicates that Fgf19 is implicated
in regulating cell proliferation and cell death but not patterning
of the midbrain and cerebellum during development of the
midbrain and cerebellum. In contrast, Fgf19 is likely to be
involved in both the establishment of the subpallial telenceph-
alon and ventral thalamus and the regulation of cell growth
during forebrain development.
Fgf19, Fgf3 and Fgf8 are required for GABAergic interneuron
and oligodendrocyte development in the forebrain
In patterning of the hindbrain and induction of the otic
placode, Fgf3 and Fgf8 expressed in the presumptive
rhombomere 4 have synergistic actions (Phillips et al.,
2001; Leger and Brand, 2002; Maroon et al., 2002; Maves
et al., 2002; Walshe et al., 2002). Both Fgf3 and Fgf8 are
also expressed in the ANB required for establishment of the
subpallial telencephalon. Inhibition of both Fgf3 and Fgf8
results in an expanded expression of emx1 and reduced
expression of dlx2 in the forebrain (Shinya et al., 2001;
Walshe and Mason, 2003). This effect is similar to that
caused by inhibition of Fgf19. Dlx2 regulates differentiation
of GABAergic interneurons and oligodendrocytes in the
telencephalon (Bertrand et al., 2002). Dlx2 has been shown
to induce a GABAergic marker, GAD1, when ectopically
expressed in cortical explants (Schuurmans and Guillemot,
2002). Although the co-injection of Fgf3 MO and Fgf8 MO
resulted in a slight reduction of gad1 and a marker for the
oligodendrocytes, olig2, in the telencephalon, a severe
reduction of gad1 and olig2 was observed in the telence-
phalon after injection of Fgf19 MO alone. Furthermore,
overexpression of Fgf19 led to the expanded expression of
gad1 and olig2 in the forebrain. The results demonstrate that
gad1 and olig2 expression in the telencephalon is more
dependent on Fgf19 than Fgf3 and Fgf8. Fgf3 expression is
up-regulated in the telencephalon in the absence of Fgf8, and
both unique and combinatorial functions of Fgf3 and Fgf8 in
the regional patterning of the telencephalon and diencephalon
were reported (Shinya et al., 2001; Walshe and Mason, 2003).
However, inhibition of both Fgf3 and Fgf8 did not affect
Fgf19 expression in the forebrain. In contrast, inhibition of
Fgf19 resulted in up-regulated expression of both Fgf3 and
Fgf8 in the telencephalon. This indicates that the Fgf19
knockdown’s effect on the specification of GABAergic
interneurons and oligodendrocytes cannot be compensatedby Fgf3 and Fgf8 up-regulated in the telencephalon.
Accordingly, it is suggested that Fgf19 is more crucial for
the differentiation of GABAergic interneurons and oligoden-
drocytes than Fgf3 and Fgf8, and these Fgfs have no
redundant function in the specification of GABAergic
interneurons and oligodendrocytes in the telencephalon. On
the other hand, Fgf19, Fgf3 and Fgf8 were required for the
expression of gad1 and olig2 in the ventral thalamus,
indicating that these Fgfs are required for the specification
of GABAergic interneurons and oligodendrocytes in the
ventral thalamus. Furthermore, Fgf3 and Fgf8 were not
required for growth of the forebrain (Shinya et al., 2001;
Walshe and Mason, 2003), whereas Fgf19 was involved in
cell proliferation in the forebrain. Therefore, it is likely that
Fgf19 has distinct functions independent from those of Fgf3
and Fgf8 in forebrain development. However, we cannot rule
out a possibility that specification of GABAergic interneurons
and oligodendrocytes in the ventral forebrain is suppressed
due to reduced cell proliferation caused by inhibition of
Fgf19 because we cannot temporally control inhibition of
Fgf19 functions.
Fgf19 is regulated by Hh signaling and Fgf3 and Fgf8
signaling during brain development
Hh signaling and Fgf signaling affect DV patterning,
specification of cell fates and cell proliferation in the
vertebrate brain (Rowitch et al., 1999; Jessell, 2000;
Vasiliauskas and Stern, 2001; Wijgerde et al., 2002; Thibert
et al., 2003; Wilson and Houart, 2004). Shh is a general
ventralizing factor in the developing vertebrate neural tube. In
the brain, mice lacking Shh lack ventral forebrain structures
(Chiang et al., 1996). Loss of Hh signaling leads to
deficiencies in ventral forebrain specification in zebrafish
(Varga et al., 2001). Shh signaling is also required for
patterning of the telencephalon (Varga et al., 2001). As Shh is
expressed in the ventral but not dorsal regions of the brain,
the effects in the absence of Shh signaling in the dorsal
regions appear to be indirect. This indicates that a Shh-
dependent signal relayed between the ventral and dorsal
regions coordinates DV patterning of the forebrain. Neural
patterning defects in the Fgf19 MO-injected embryos were
similar to those seen in smu/smo mutants. Fgf19 was
expressed in both dorsal and ventral regions of the brain.
Furthermore, the expression of Fgf19 in the forebrain was
severely reduced by inhibition of Hh signaling at 15 and 25
hpf. Our results imply that the effects of Hh activity on
patterning of the telencephalon and diencephalon are likely to
be mediated by Fgf19. In addition, the expression of Fgf19 in
the midbrain and cerebellum was reduced by inhibition of Hh
signaling in zebrafish at 15 and 25 hpf. As no Fgf15
expression was observed in the diencephalic/midbrain region
between the 12- and 16-somite stages in Shh mutant mice,
Shh is also required for Fgf15 expression (Ishibashi and
McMahon, 2002). In Shh mutant mice, cell proliferation is
decreased in alar plates of the brain, indicating that Shh has a
mitogenic role in the brain (Ishibashi and McMahon, 2002).
A. Miyake et al. / Developmental Biology 288 (2005) 259–275 273The ectopic expression of Hh target genes causes human
cancers such as basal cell carcinoma or medulloblastoma, a
granule cell tumor (Rowitch et al., 1999; Ruiz i Altaba et al.,
2002). The Fgf19 MO-injected zebrafish embryos as well as
Shh mutant mice showed decreased cell proliferation in the
dorsal region of the brain. These results indicate that Fgf19 is
likely to function downstream of Hh activity in cell
proliferation and contributes as a positive mediator of Hh
signaling to the activation of some Hh target genes. Inhibition
of both Fgf3 and Fgf8 also led to a reduction of Fgf19
expression in the midbrain. Fgf8 participates in the growth of
the midbrain (Sato et al., 2001). However, Fgf8 is expressed
in the presumptive MHB from 9 hpf but not the midbrain
(Reifers et al., 1998). Fgf8 expressed in the MHB may
regulate cell proliferation in the midbrain by activating Fgf19
expression in the midbrain. Thus, it is suggested that Fgf19
expression is regulated by Hh signaling from the ventral
region in the forebrain and also by both Fgf3 and Fgf8
signaling from the MHB territory and Hh signaling from the
ventral region in the midbrain.
Hh signaling is required for oligodendrocyte development in
zebrafish (Park et al., 2002). The expression of Olig2 is lost in
Shh/ mutant mice (Alberta et al., 2001). Shh is involved in
the generation of GABAergic neuronal/oligodendrocyte pro-
genitors from ventral forebrain stem cells via the activation of
Olig2 (Yung et al., 2002). Overexpression of Fgf19 rescued the
expression of gad1 and olig2 in the embryos with inhibited Hh
signaling. In addition to Fgf19, the expression of Fgf3 and
Fgf8 in the forebrain was severely reduced by inhibition of Hh
signaling at 15 hpf. Therefore, we believe that Hh signaling
specifies GABAergic interneurons and oligodendrocytes via
Fgf19, Fgf3 and Fgf8 which ensure the expression of pan-
ventral transcription factors, such as dlx2 and olig2, in the
ventral region of the forebrain.
In conclusion, the present findings indicate that Fgf19
expressed in the developing brain plays crucial roles in brain
development. Fgf19 is involved in cell proliferation and cell
survival in the forebrain, midbrain and cerebellum. In the
forebrain, Fgf19 also plays crucial roles in the development
of the ventral region and specification of GABAergic
interneurons and oligodendrocytes. Furthermore, Fgf19 ex-
pression was dependent on Hh and overexpression of Fgf19
rescued the phenotype on inhibition of Hh signaling in the
forebrain. The present findings indicate that cross talk
between Fgf19 signaling and Hh signaling is crucial for cell
proliferation, cell survival, regionalization and cell type
specification as the forebrain develops and provide new
insights into the roles of Fgf signaling in the brain’s
development.
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